Literature DB >> 1882019

Symptoms of depression in patients with type II diabetes mellitus.

L Leedom1, W P Meehan, W Procci, A Zeidler.   

Abstract

Patients with type II diabetes mellitus were assessed for symptoms of depression using the Zung Self-Rated Depression Scale (Zung SDS) and the Beck Depression Inventory (BDI). The patients were classified according to the presence or absence of diabetic complications, and they were compared with a group of demographically matched, nonmedically ill control subjects. The patients with diabetic complications scored significantly higher on the depression inventories than did the patients without complications and the control subjects. Factor analysis of BDI responses revealed that cognitive symptoms of depression were prominent in the diabetic patients with complications. In this group, 74% of patients scored within the range of clinical depression on the BDI; 35% scored within the range of severe depression. Symptoms of sexual dysfunction were significantly correlated with symptoms of depression in diabetic women but not in diabetic men. The findings are discussed within the context of other research in the behavioral aspects of diabetes mellitus.

Entities:  

Mesh:

Year:  1991        PMID: 1882019     DOI: 10.1016/S0033-3182(91)72066-5

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  10 in total

Review 1.  Type II diabetes and quality of life: a review of the literature.

Authors:  J O Hörnquist; A Wikby; U Stenström; P O Andersson; I Akerlind
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

2.  Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.

Authors:  Richard R Rubin; William C Knowler; Yong Ma; David G Marrero; Sharon L Edelstein; Elizabeth A Walker; Sanford A Garfield; Edwin B Fisher
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  The health status of diabetic patients receiving orthotic therapy.

Authors:  S Davies; O Gibby; C Phillips; P Price; W Tyrrell
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

Review 4.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Authors:  Richard R Rubin; Yong Ma; David G Marrero; Mark Peyrot; Elizabeth L Barrett-Connor; Steven E Kahn; Steven M Haffner; David W Price; William C Knowler
Journal:  Diabetes Care       Date:  2007-12-10       Impact factor: 19.112

6.  Depression in Asthma: Prevalence and Clinical Implications.

Authors:  Tanya A. Zielinski; E Sherwood Brown; Vicki A. Nejtek; David A. Khan; Jacob J. Moore; A John Rush
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

Review 7.  Cerebral function in diabetes mellitus.

Authors:  G J Biessels; A C Kappelle; B Bravenboer; D W Erkelens; W H Gispen
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

8.  Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain.

Authors:  S V Tembhurne; D M Sakarkar
Journal:  Res Pharm Sci       Date:  2010-01

9.  Determine the relationship between perceived social support and depression level of patients with diabetic foot.

Authors:  Ebru Yildiz; Türkinaz Aşti
Journal:  J Diabetes Metab Disord       Date:  2015-07-16

10.  Evaluation of anxiety condition among type 1 and type 2 diabetic patients.

Authors:  Aliye Bulut; Aziz Bulut
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-11       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.